Expression and cell-specific localization of cholecystokinin receptors in rat lung

World Journal of Gastroenterology

Volumn 9, Issue 6, 2003, Pages 1273-1277

  Cong, Bin ^a   Li, Shu Jin ^a   Ling, Yi Ling ^a   Yao, Yu Xia ^a   Gu, Zhen Yong ^a   Wang, Jun Xia ^a   You, Hong Yu ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BRAIN; BRONCHUS MUCOSA; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; IN SITU HYBRIDIZATION; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR OCCUPANCY; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; STAINING; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM;

EID: 0038051549     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i6.1273     Document Type: Article

References (35)

1. Crawley JN, Corwin RL. Biological actions of cholecystokinin. Peptides 1994; 15: 731-755
2. Wank SA. Chokecystokinin receptors. Am J Physiol 1995; 269: G628-G646
3. Noble F, Roques BP. CCK-B receptor: Chemistry, molecular biology, biochemistry and pharmacology. Progress in Neurobiol 1999; 58: 349-379
4. Kulaksiz H, Arnold R, Goke B, Maronde E, Meyer M, Fahrenholz F, Forssmann WG, Eissele R. Expression and cell-specific localization of the cholecystokinin B/ gastrin receptor in the human stomach. Cell Tissue Res 2000; 299: 289-298
5. Wank SA. G protein-coupled receptors in gastrointestinal physiology. I. CCK receptors: An exemplary family. Am J Physiol 1998; 274: G607-G613
6. Smith JP, Verderame MF, McLaughlin P, Martenis M, Ballard E, Zagon IS. Characterization of the CCK-C (cancer) receptor in human pancreatic cancer. Int J Mol Med 2002; 10: 689-694
7. Clerc P, Leung-Theung-Long S, Wang TC, Dockray GJ, Bouisson M, Delisle MB, Vaysse N, Pradayrol L, Fourmy D, Dufresne M. Expression of CCK2 receptors in the murine pancreas: Proliferation transdifferentiation of acinar cells, and neoplasia. Gastroenterology 2002; 122: 428-437
8. Pagliocca A, Wroblewski LE, Ashcroft FJ, Noble PJ, Dockray GJ, Varro A. Stimulation of the gastrin-cholecystokinin(B) receptor promotes branching morphogenesis in gastric AGS cells. Am J Physiol Gastrointest Liver Physiol 2002; 283: G292-G299
9. Henwood M, Clarke PA, Smith AM, Watson SA. Expression of gastrin in developing gastric adenocarcinoma. Br J Surg 2001; 88: 564-568
10. Fontana MG, Moneghini D, Villanacci V, Donato F, Rindi G. Effect of cholecystokinin-B gastrin receptor blockade on chemically induced colon carcinogenesis in mice: Follow-up at 52 weeks. Digestion 2002; 65: 35-40
11. Reubi JC, Schaer JC, Waser B. Cholecystokinin(CCK)-A and CCK-B/ gastrin receptors in human tumors. Cancer Res 1997; 57: 1377-1386
12. Matsumori Y, Katakami N, Ito M, Taniguchi T, Iwata N, Takaishi T, Chihara K, Matsui T. Cholecystokinin-B/ gastrin receptor: A novel molecular probe for human small cell lung cancer. Cancer Res 1995; 55: 276-279
13. Behr TM, Jenner N, Radetzky S, Behe M, Gratz S, Yucekent S, Raue F, Becker W. Targeting of cholecystokinin-B/ gastrin receptor in vivo: Preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin. Eur J Nucl Med 1998; 25: 424-430
14. Dornand J, Roche S, Michel F, Bali JP, Cabane S, Favero J, Magous R. Gastrin-CCK-B type receptors on human T lymphoblastoid Jurkat cells. Am J Physiol 1995; 268: G522-529
15. Oiry C, Gagne D, Cottin E, Bernard N, Galleyrand JC, Berge G, Lignon MF, Eldin P, Le Cunff M, Leger J, Clerc P, Fourmy D, Martinez J. Cholecystokinin B receptor from human Jurkat lymphobolastic T cells is involved in activator protein-1-responsive gene activation. Mol Pharmacol 1997; 52: 292-299
16. Medina S, Rio MD, Cuadra BD, Guayerbas N, Fuente MD. Age-related changes in the modulatory action of gastrin-releasing peptide, neuropeptide Y and sulfated cholecystokinin octapeptide in the proliferation of murine lymphocytes. Neuropeptides 1999; 33: 173-179
17. De La Fuente M, Carrasco M, Del Rio M, Hernanz A. Modulation of murine lymphocyte functions by sulfated cholecystokinin octapeptide. Neuropeptides 1998; 32: 225-33
18. Mercer DW, Cross JM, Smith GS, Miller TA. Protective action of gastrin-17 against alcohol-induced gastric injury in the rat: Role in mucosal defense. Am J Physiol 1997; 273: G365-G373
19. Mercer DW, Cross JM, Chang L, Lichtenberger LM. Bombesin prevents gastric injury in the rat: Role of gastrin. Dig Dis Sci 1998; 43: 826-833
20. Mercer DW, Smith GS, Miller TA. Cyclooxygenase inhibition attenuates cholecystokinin-induced gastroprotection. Dig Dis Sci 1998; 43: 468-475
21. Ling YL, Huang SS, Wang LF, Zhang JL, Wan M, Hao RL. Cholecystokinin octapeptide reverses experimental endotoxin shock. Shengli Xuebao 1996; 48: 390-394
22. Ling YL, Cong B, Gu ZY, Li SJ, Zhou XH. Inhibitory effect of cholecystokinin octapeptide on pulmonary arterial hypertension during endotoxic shock. Zhongguo Xueshu Qikan Wenzhai 2000; 6: 890-892
23. Gu ZY, Ling YL, Meng AH, Cong B, Hung SS. Effects of cholecystokin-octapeptide on the response of rabbit pulmonary artery induced by LPS in vitro. Zhongguo Bingli Shengli Zazhi 1999; 15: 484-487
24. Stretton CD, Barnes PJ. Cholecystokinin-octapeptide constricts guinea-pig and human airways. Br J Pharmacol 1989; 97: 675-682
25. Monstein HJ, Nylander AG, Salehi A, Chen D, Lundquist I, Hakanson R. Cholecystokinin-A and cholecystokinin-B / gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. Scand J Gastroenterol 1996; 31: 383-390
26. Bartlett JM. Approaches to the analysis of gene expression using mRNA: A technical overview. Mol Biotechnol 2002; 21: 149-160
27. Peters J, Krams M, Wacker HH, Carstens A, Weisner D, Hamann K, Menke M, Harms D, Parwaresch R. Detection of rare RNA sequences by single-enzyme in situ reverse transcription-polymerase chain reaction. Am J Pathol 1997; 150: 469-476
28. Meng AH, Ling YL, Wang DH, Gu ZY, Li SJ, Zhu TN. Role of nitric oxide in cholecystokinin-octapeptide alleviation of tumor necrosis factor-alpha induced changes in rabbit pulmonary arterial reactivity. Shengli Xuebao 2001; 53: 478-482
29. Gu ZY. Peroxynitrite-mediated pulmonary vascular injury induced by endotoxin and the protective role of cholecystokinin. Shengli Kexue Jinzhan 2001; 32: 135-137
30. Tobias PS, Tapping RI, Gegner JA. Endotoxin interactions with lipopolysaccharide-responsive cells. Clin Infec Dis 1999; 28: 476-481
31. Salomao R, Rigato O, Pignatari AC, Freudenberg MA, Galanos C. Bloodstream infections: Epidemiology, pathophysiology and therapeutic perspectives. Infection 1999; 27: 1-11
32. Li SJ, Cong B, Yan YL, Yao YX, Ma CL, Ling YL. Cholecystokinin octapeptide inhibits the in vitro expression of CD14 in rat pulmonary interstitial macrophages induced by lipopolysaccharide. Chin Med J (English Issue) 2002; 115: 276-279
33. Cong B, Li SJ, Yao YX, Zhu GJ, Ling YL. Effect of cholecystokinin octapeptide on tumor necrosis factor α transcription and nuclear factor-κB activity induced by lipopolysaccharide in rat pulmonary interstitial macrophages. World J Gastroenterol 2002; 8: 718-723
34. De La Fuente M, Campos M, Del Rio M, Hernanz A. Inhibition of murine peritoneal macrophage functions by sulfated cholecystokinin octapeptide. Regul Pept 1995; 55: 47-56
35. De La Fuente M, Medina S, Del Rio M, Ferrandez MD, Hernanz A. Effect of aging on the modulation of macrophage functions by neuropeptides. Life Sci 2000; 67: 2125-2135